about
The farther, the safer: a manifesto for securely navigating synthetic species away from the old living worldMitigating the looming vaccine crisis: production and delivery of plasmid-based vaccinesProtective efficacy of a human endogenous retrovirus envelope-coated, nonreplicable, baculovirus-based hemagglutin vaccine against pandemic influenza H1N1 2009.Prospects for control of emerging infectious diseases with plasmid DNA vaccines.The murine intravaginal HSV-2 challenge model for investigation of DNA vaccines.Comparative analysis of macrophage associated vectors for use in genetic vaccineComparison of immune response generated against Japanese encephalitis virus envelope protein expressed by DNA vaccines under macrophage associated versus ubiquitous expression promotersSurface display of an anti-DEC-205 single chain Fv fragment in Lactobacillus plantarum increases internalization and plasmid transfer to dendritic cells in vitro and in vivoProduction of Recombinant Peanut Allergen Ara h 2 using Lactococcus lactis.VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection.Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system.Rational engineering of Escherichia coli strains for plasmid biopharmaceutical manufacturing.Improved Specificity of Gene Electrotransfer to Skin Using pDNA Under the Control of Collagen Tissue-Specific Promoter.The scientific impact of microbial cell factories.Live Bacterial Vectors-A Promising DNA Vaccine Delivery System.
P2860
Q24655357-03F57441-45D8-4D50-ABDF-D8079D39717CQ28294355-6BDA518F-44C7-4689-B070-82984C45C1E9Q30355851-345CC8C5-9193-43F0-BDE1-0499A87B3252Q30380454-0F1A06AD-75E5-49D6-B37B-5EC52BE2912FQ33856067-4933FEAE-B439-454F-A683-B044390F41CFQ35137219-D791EE32-7027-455C-B620-9C65BCFC9833Q35179151-18EC3E2C-40F9-4701-9312-1712808E3767Q35816760-326B64EC-E1BF-41BD-ACE2-272582C21AA6Q36025631-B9FDEB63-2E21-47B9-8DAD-F0D3571B9D42Q36517156-5FF33218-F314-41F8-95CB-9B784030096BQ37398200-3D6C6DF1-0C2B-46EB-86FC-E815268A9987Q37399763-F06D4E9E-702D-4492-B23E-A89D97AC629BQ37931183-85FA888B-CF18-45EA-808B-73136B088820Q42150743-176DD73E-E185-4ED5-A31B-F806D40A5660Q43194023-E04C737A-BC74-4401-BDD6-170B4E1E7E24Q52640510-7C9FA0C1-5AAA-4223-99F6-172FC8692C21
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Ensuring safety of DNA vaccines
@nl
Ensuring safety of DNA vaccines.
@ast
Ensuring safety of DNA vaccines.
@en
type
label
Ensuring safety of DNA vaccines
@nl
Ensuring safety of DNA vaccines.
@ast
Ensuring safety of DNA vaccines.
@en
prefLabel
Ensuring safety of DNA vaccines
@nl
Ensuring safety of DNA vaccines.
@ast
Ensuring safety of DNA vaccines.
@en
P2860
P356
P1476
Ensuring safety of DNA vaccines.
@en
P2093
Jacob Glenting
Stephen Wessels
P2860
P2888
P356
10.1186/1475-2859-4-26
P407
P577
2005-09-06T00:00:00Z
P5875
P6179
1049907330